"lung cancer" trang 6 - tải miễn phí từ tailieuXANH
Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
9    71    0
The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis

The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis
9    68    0
Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J

Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J
14    66    0
Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy

Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy
13    46    0
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer

Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer
8    43    0
Pneumonitis after radiotherapy for lung cancer (PARALUC): An interventional study to create a symptom-based scoring system for identification of patients developing radiation pneumonitis

Pneumonitis after radiotherapy for lung cancer (PARALUC): An interventional study to create a symptom-based scoring system for identification of patients developing radiation pneumonitis
9    77    0
High expression of AGR2 in lung cancer is predictive of poor survival

High expression of AGR2 in lung cancer is predictive of poor survival
9    66    0
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients
10    71    0
Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer
7    68    0
The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: A meta-analysis

The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: A meta-analysis
9    58    0
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer
10    56    0
MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1
11    59    0
Osimertinib in advanced EGFRT790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

Osimertinib in advanced EGFRT790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
12    40    1
Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer

Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer
17    36    1
Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocytemonocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy

Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocytemonocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy
13    38    1
Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively

Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively
10    34    1
Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings

Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings
13    37    1
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using reallife data

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using reallife data
11    337    1
Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1- rearranged advanced non-small cell lung cancer (NSCLC) in Canada

Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1- rearranged advanced non-small cell lung cancer (NSCLC) in Canada
13    70    1
Associations between female lung cancer risk and sex steroid hormones: A systematic review and meta-analysis of the worldwide epidemiological evidence on endogenous and exogenous sex steroid hormones

Associations between female lung cancer risk and sex steroid hormones: A systematic review and meta-analysis of the worldwide epidemiological evidence on endogenous and exogenous sex steroid hormones
10    98    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.